BioMaxima S.A.

Total Valuation

BioMaxima S.A. carries a market capitalization of 39.37M, placing it among publicly traded companies globally. Its enterprise value stands at 68.14M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

BioMaxima S.A. currently has 4.19M shares outstanding.

Valuation Ratios

BioMaxima S.A. trades at a trailing price-to-earnings ratio of 60.86. The price-to-sales ratio is 0.94, and the price-to-book ratio stands at 1.40.

Enterprise Valuation

On an enterprise value basis, BioMaxima S.A. trades at an EV/EBITDA multiple of 44.33 and an EV/FCF ratio of 98.51. The EV/Sales ratio of 1.20 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 44.33 provides insight into valuation relative to core operating earnings.

Financial Position

BioMaxima S.A. maintains a current ratio of 1.44, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 32.46, indicating elevated leverage, while an interest coverage ratio of 1.49 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, BioMaxima S.A. has paid -138,000.00 in income taxes, reflecting an effective tax rate of 13.89.

Stock Price Statistics

BioMaxima S.A.'s stock has declined approximately -35.90444% over the past 52 weeks. The 50-day moving average sits at 10.46, while the 200-day moving average is 11.95.

Income Statement

Over the trailing twelve months, BioMaxima S.A. generated 56.60M in revenue and converted that into 874,000.00 in net income, yielding earnings per share of 0.21. EBITDA reached 1.54M, while operating income came in at 1.54M.

Balance Sheet

BioMaxima S.A. holds 576,000.00 in cash and equivalents against 15.52M in total debt, resulting in a net debt position of 14.19M. Total book value stands at 37.86M, with working capital of 8.91M providing operational flexibility.

Cash Flow

BioMaxima S.A. produced -1.04M in operating cash flow over the past twelve months. After subtracting -502,000.00 in capital expenditures, free cash flow totaled -1.54M - equivalent to -0.37 per share.

Margins

BioMaxima S.A. operates with a gross margin of 46.00, reflecting its pricing power and cost economics. The operating margin of 2.72 and net profit margin of 1.54 provide insight into operational efficiency.

Dividends & Yields

Scores

BioMaxima S.A. posts an Altman Z-Score of 2.52, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.